AC Immune
Florian Udry is currently working as a Junior IP Associate at AC Immune since April 2022. Previously, Florian served as a Board Member at BSNL BioScience Network Lausanne from March 2015 to May 2020, and as an Equipier at McDonald's Corporation from February 2012 to February 2013. Additionally, Florian worked as a Collaborateur scientifique at Fondation Asile des aveugles, Hôpital ophtalmique Jules-Gonin from March 2014 to April 2022, focusing on the development of an innovative therapy for inherited retinal degenerations. Prior to this, Florian was involved in research as a Post-Doc Researcher and a PhD student, also concentrating on the development of a therapy for inherited retinal degenerations.
This person is not in any teams
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.